文献速递神经免疫

基因组测序揭示原发性进展型多发性硬化中的表型拷贝

Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
PubMed 文献 · Ann Neurol · 2018-07-03

研究对38例原发性进展型多发性硬化(PPMS)和81名健康对照进行全基因组测序,发现3个致单基因神经疾病的致病性变异,并在扩展样本中证实PPMS和继发进展型多发性硬化(SPMS)患者中遗传性痉挛性截瘫(HSP)相关基因突变负荷显著富集,而复发型多发性硬化(RMS)中未检测到该富集。

要点

  • PPMS患者中鉴定出KIF5A、MLC1和REEP1基因的致病性变异,分别对应遗传性痉挛性截瘫10型、伴皮质下囊肿的巨脑性白质脑病和遗传性痉挛性截瘫31型。
  • HSP相关基因突变在PPMS患者中较对照显著富集(RR=1.95,95%CI 1.27-2.98,p=0.002),在SPMS患者中亦显著富集(RR=1.57,95%CI 1.18-2.10,p=0.002)。
  • RMS患者中未检测到HSP相关基因突变富集。

核心结论

  • 研究提供证据支持罕见孟德尔遗传变异 contribute 于进展型多发性硬化发病风险的假说。

研究设计与样本

  • 对38例PPMS患者和81名欧洲裔健康对照进行全基因组测序,筛选仅见于PPMS患者的致单基因神经疾病致病性变异,并在746例PPMS、3049例RMS和1000名健康对照中进行两轮复制基因分型。
  • 进一步使用MS复制芯片对314例PPMS、587例SPMS、2248例RMS和987名健康对照进行41个遗传性痉挛性截瘫(HSP)相关基因的罕见潜在致病突变负荷分析。

主要发现

  • 全基因组测序和复制研究在PPMS患者中鉴定出三个致神经疾病的致病性变异:KIF5A p.Ala361Val(遗传性痉挛性截瘫10型)、MLC1 p.Pro92Ser(伴皮质下囊肿的巨脑性白质脑病)和REEP1 c.606+43G>T(遗传性痉挛性截瘫31型)。
  • PPMS患者较健康对照HSP相关突变显著富集(RR=1.95;95%CI 1.27-2.98;p=0.002)。
  • SPMS患者较健康对照HSP相关突变亦显著富集(RR=1.57;95%CI 1.18-2.10;p=0.002)。
  • RMS患者中未检测到HSP相关突变富集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Primary progressive multiple sclerosis (PPMS) causes accumulation of neurological disability from disease onset without clinical attacks typical of relapsing multiple sclerosis (RMS). However, whether genetic variation influences the disease course remains unclear. We aimed to determine whether mutations causative of neurological disorders that share features with multiple sclerosis (MS) contribute to risk for developing PPMS. METHODS: We examined whole-genome sequencing (WGS) data from 38 PPMS and 81 healthy subjects of European ancestry. We selected pathogenic variants exclusively found in PPMS patients that cause monogenic neurological disorders and performed two rounds of replication genotyping in 746 PPMS, 3,049 RMS, and 1,000 healthy subjects. To refine our findings, we examined the burden of rare, potentially pathogenic mutations in 41 genes that cause hereditary spastic paraplegias (HSPs) in PPMS (n = 314), secondary progressive multiple sclerosis (SPMS; n = 587), RMS (n = 2,248), and healthy subjects (n = 987) genotyped using the MS replication chip. RESULTS: WGS and replication studies identified three pathogenic variants in PPMS patients that cause neurological disorders sharing features with MS: KIF5A p.Ala361Val in spastic paraplegia 10; MLC1 p.Pro92Ser in megalencephalic leukodystrophy with subcortical cysts, and REEP1 c.606 + 43G>T in Spastic Paraplegia 31. Moreover, we detected a significant enrichment of HSP-related mutations in PPMS patients compared to controls (risk ratio [RR] = 1.95; 95% confidence interval [CI], 1.27-2.98; p = 0.002), as well as in SPMS patients compared to controls (RR = 1.57; 95% CI, 1.18-2.10; p = 0.002). Importantly, this enrichment was not detected in RMS. INTERPRETATION: This study provides evidence to support the hypothesis that rare Mendelian genetic variants contribute to the risk for developing progressive forms of MS. Ann Neurol 2018;83:51-63.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Jia X, Madireddy L, Caillier S, et al. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann Neurol. 2018. PMID: 29908077. doi:10.1002/ana.25263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。